BALAXI
Invest Now
Start SIP in
BALAXI
Performance
- Low
- ₹54
- High
- ₹58
- 52 Week Low
- ₹50
- 52 Week High
- ₹151
- Open Price₹54
- Previous Close₹54
- Volume185,527
Investment Returns
- Over 1 Month -15.21%
- Over 3 Month + 4.98%
- Over 6 Month -29.95%
- Over 1 Year -58.16%
Smart Investing Starts Here Start SIP with Balaxi Pharmaceuticals for Steady Growth!
Balaxi Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.1
- PEG Ratio
- 0
- Market Cap Cr
- 302
- P/B Ratio
- 1.4
- Average True Range
- 3.06
- EPS
- 4.77
- Dividend Yield
- 0
- MACD Signal
- -2.68
- RSI
- 38.64
- MFI
- 33.32
Balaxi Pharmaceuticals Financials
Balaxi Pharmaceuticals Technicals
EMA & SMA
Current Price
₹54.78
+
0.36
(0.66%)

-
- Bearish Moving Average 14
-
- Bullish Moving Average 2
- 20 Day
- ₹56.72
- 50 Day
- ₹60.76
- 100 Day
- ₹66.75
- 200 Day
- ₹77.01
Resistance and Support
55.7
- R3 60.52
- R2 59.22
- R1 57.00
- S1 53.48
- S2 52.18
- S3 49.96
Balaxi Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-10 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Rs. 2/-. |
2024-11-05 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Rs. 2/-. |
2024-08-02 | Quarterly Results | |
2024-05-29 | Audited Results | |
2023-11-02 | Quarterly Results |
Balaxi Pharmaceuticals F&O
About Balaxi Pharmaceuticals
- NSE Symbol
- BALAXI
- BSE Symbol
- Managing Director
- Mr. Ashish Maheshwari
- ISIN
- INE618N01022
Similar Stocks to Balaxi Pharmaceuticals
Balaxi Pharmaceuticals FAQs
Balaxi Pharmaceuticals share price is ₹54 As on 19 May, 2025 | 19:41
The Market Cap of Balaxi Pharmaceuticals is ₹302.4 Cr As on 19 May, 2025 | 19:41
The P/E ratio of Balaxi Pharmaceuticals is 11.1 As on 19 May, 2025 | 19:41
The PB ratio of Balaxi Pharmaceuticals is 1.4 As on 19 May, 2025 | 19:41
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.